Corey Cutler
Director of the · Mass General Brigham
Credentials: · · · ·
History
- Present
- 2001–2002
Hematology
- 1999–2001
- 1996–1999
MUHC
- 1992–1996
Research
Biology of Blood and Marrow Transplantation · 2015 · 2,533 citations
Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
Gastroenterology · 1997 · 1,288 citations
Interleukin-2 and regulatory T cells in graft-versus-host disease
New England Journal of Medicine · 2011 · 929 citations
219 papers
193 papers
171 papers
148 papers · 10 as a fellow
126 papers
119 papers
109 papers
81 papers · 2 as a fellow
Grants
- 2022–2027
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
National Heart, Lung, and Blood Institute · P01
Contact PI · $12.8M · Dana-Farber Cancer Inst
- 2009–2021
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
National Cancer Institute · P01
Contact PI · $8.2M · Dana-Farber Cancer Inst
- 2013–2018
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity After UCBT
National Cancer Institute · R01
PI · $3.1M · Beth Israel Deaconess Medical Center
Clinical trials
- 2024–2027
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Principal investigator · Recruiting · Phase 2
Dana-Farber Cancer Institute
- 2016–2024
Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
- 2015–2019
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
- 2011–2013
Principal investigator · Completed · Phase 1
Fate Therapeutics